Role of human papilloma virus testing in cervical cancer prevention
- PMID: 14710135
- DOI: 10.1016/j.jmwh.2003.10.002
Role of human papilloma virus testing in cervical cancer prevention
Abstract
A clear causal relationship has been established between human papilloma virus (HPV) infection and the development of cervical cancer. Genital HPV infection is currently the most common sexually transmitted disease worldwide. The recent 2001 American Society for Colposcopy and Cervical Pathology Consensus Guidelines have included HPV testing for management of women with cervical cytological abnormalities. Clinicians now face the challenge of deciding when to use HPV testing in follow-up of abnormal Pap tests. This article includes updates on HPV, cervical cancer screening, and HPV testing technology. Recommendations for integration of HPV testing into clinical practice are provided.
Similar articles
-
Human papillomavirus testing for primary cervical cancer screening.Expert Rev Mol Diagn. 2008 Sep;8(5):599-605. doi: 10.1586/14737159.8.5.599. Expert Rev Mol Diagn. 2008. PMID: 18785808 Review.
-
Cervical cancer screening in the early post vaccine era.Obstet Gynecol Clin North Am. 2008 Dec;35(4):537-48; vii. doi: 10.1016/j.ogc.2008.09.005. Obstet Gynecol Clin North Am. 2008. PMID: 19061815 Review.
-
Human papillomavirus in cervical screening and vaccination.Clin Sci (Lond). 2006 May;110(5):543-52. doi: 10.1042/CS20050230. Clin Sci (Lond). 2006. PMID: 16597323 Review.
-
Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?Arch Intern Med. 2010 Jun 14;170(11):977-85. doi: 10.1001/archinternmed.2010.134. Arch Intern Med. 2010. PMID: 20548011
-
Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.Vaccine. 2007 Apr 20;25(16):3007-13. doi: 10.1016/j.vaccine.2007.01.016. Epub 2007 Jan 18. Vaccine. 2007. PMID: 17292517 Review.
Cited by
-
Knowledge, attitude, and experience of cervical cancer and screening among Sub-saharan African female students in a UK University.Ann Afr Med. 2017 Jan-Mar;16(1):18-23. doi: 10.4103/aam.aam_37_16. Ann Afr Med. 2017. PMID: 28300047 Free PMC article.
-
Association of XRCC3 18067 C>T (Thr241Met) polymorphism with risk of cervical and ovarian cancers: A systematic review and meta-analysis.Interv Med Appl Sci. 2019 Oct 7;11(3):172-181. doi: 10.1556/1646.11.2019.21. eCollection 2020 Sep. Interv Med Appl Sci. 2019. PMID: 36343295 Free PMC article. Review.
-
Comprehensive proteomic analysis of human cervical-vaginal fluid using colposcopy samples.Proteome Sci. 2009 Apr 17;7:17. doi: 10.1186/1477-5956-7-17. Proteome Sci. 2009. PMID: 19374746 Free PMC article.
-
Use of cervicovaginal fluid for the identification of biomarkers for pathologies of the female genital tract.Proteome Sci. 2010 Dec 8;8:63. doi: 10.1186/1477-5956-8-63. Proteome Sci. 2010. PMID: 21143851 Free PMC article.
-
A Glimmer of Hope for Patients with a T3 Transformation Zone: miRNAs Are Potential Biomarkers for Cervical Dysplasia.Diagnostics (Basel). 2023 Dec 5;13(24):3599. doi: 10.3390/diagnostics13243599. Diagnostics (Basel). 2023. PMID: 38132183 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials